Nanoparticle innovation promises improved type 1 diabetes treatment

Researchers at Northwestern University have developed a new kind of nanotherapy to enhance the effectiveness of a potential cure for type 1 diabetes. The innovation packages immunosuppressive drugs into nanoparticles to reduce the likelihood of a body rejecting newly transplanted islet cells.